Tag: Raghuram Selvaraju

Dr. Raghuram “Ram” Selvaraju, Ph.D. is a Managing Director of Equity Research at H.C. Wainwright & Co. whose research focuses on the healthcare sector. Prior to joining H.C. Wainwright, Dr. Selvaraju held Senior Research positions at MLV & Co., Aegis Capital, Hapoalim Securities USA, and Rodman & Renshaw LLC. Dr. Selvaraju’s educational background includes a Ph.D. in molecular neuroscience and cellular immunology, an M.S. degree in molecular biology from the University of Geneva in Switzerland, and an MBA from Cornell University.